Filing Details

Accession Number:
0001181431-13-033690
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-07 19:35:51
Reporting Period:
2013-06-05
Filing Date:
2013-06-07
Accepted Time:
2013-06-07 19:35:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
878526 Natus Medical Inc BABY Electromedical & Electrotherapeutic Apparatus (3845) 770154833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208700 M Kenneth Traverso C/O Natus Medical Incorporated
1501 Industrial Road
San Carlos CA 94070
Vp Marketing And Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2013-06-05 22,682 $4.51 144,926 No 4 M Direct
Common Stock, $0.001 Par Value Per Share Disposition 2013-06-05 22,682 $14.30 122,244 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (Right to Buy) Acquisiton 2013-06-05 8,582 $0.00 8,582 $4.51
Common Stock Non-Qualified Stock Option Acquisiton 2013-06-05 14,100 $0.00 34,100 $4.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-03-25 2014-02-25 No 4 M Direct
20,000 2006-12-25 2014-02-25 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share 8,572 Indirect By Family Trust
Common Stock, $0.001 Par Value Per Share 10,500 Indirect By IRA
Common Stock, $0.001 Par Value Per Share 4,100 Indirect By IRA for Spouse
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $14.26 to $14.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.